200 related articles for article (PubMed ID: 36060673)
21. Progestin-Primed Ovarian Stimulation with Clomiphene Citrate Supplementation May Be More Feasible for Young Women with Diminished Ovarian Reserve Compared with Standard Progestin-Primed Ovarian Stimulation: A Retrospective Study.
Lin Y; Chen Q; Zhu J; Teng Y; Huang X; Chen X
Drug Des Devel Ther; 2021; 15():5087-5097. PubMed ID: 34992345
[TBL] [Abstract][Full Text] [Related]
22. Comparison of a progestin-primed ovarian stimulation protocol with a flexible GnRH antagonist protocol in patients with polycystic ovary syndrome who are participating in an IVF programme: study protocol for a randomised controlled trial.
Wang N; Zhu Q; Ma M; Liang Z; Tao Y; Wang Y; Kuang Y
BMJ Open; 2020 Dec; 10(12):e038153. PubMed ID: 33268401
[TBL] [Abstract][Full Text] [Related]
23. Clomiphene citrate is associated with favorable cycle characteristics but impaired outcomes of obese women with polycystic ovarian syndrome undergoing ovarian stimulation for in vitro fertilization.
Jiang S; Kuang Y
Medicine (Baltimore); 2017 Aug; 96(32):e7540. PubMed ID: 28796038
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of Different Progestins in Women With Advanced Endometriosis Undergoing Controlled Ovarian Hyperstimulation for
Guo H; Li J; Shen X; Cong Y; Wang Y; Wu L; Li B; Gao H; Ma M; Zhang W; Mao X; Fu Y; Lyu Q; Chai W; Kuang Y
Front Endocrinol (Lausanne); 2020; 11():129. PubMed ID: 32265834
[No Abstract] [Full Text] [Related]
25. Comparison of cumulative live birth rates between progestin-primed ovarian stimulation protocol and gonadotropin-releasing hormone antagonist protocol in different populations.
Zhou R; Dong M; Huang L; Wang S; Fan L; Liang X; Zhang X; Liu F
Front Endocrinol (Lausanne); 2023; 14():1117513. PubMed ID: 37143731
[TBL] [Abstract][Full Text] [Related]
26. Mild ovarian stimulation with letrozole plus fixed dose human menopausal gonadotropin prior to IVF/ICSI for infertile non-obese women with polycystic ovarian syndrome being pre-treated with metformin: a pilot study.
D'Amato G; Caringella AM; Stanziano A; Cantatore C; Palini S; Caroppo E
Reprod Biol Endocrinol; 2018 Sep; 16(1):89. PubMed ID: 30217209
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of progestin-primed ovarian stimulation (PPOS) versus minimal stimulation in women of advanced maternal age with poor ovarian response under the Patient-Oriented Strategies Encompassing Individualized Oocyte Number (POSEIDON) criteria.
Zhao S; Wang C
Ann Palliat Med; 2023 Jan; 12(1):133-140. PubMed ID: 36747387
[TBL] [Abstract][Full Text] [Related]
28. Progestin-primed ovarian stimulation versus GnRH antagonist protocol in poor responders: Risk of premature LH surge and outcome of oocyte retrieval.
Kao TC; Hsieh YC; Yang IJ; Wu MY; Chen MJ; Yang JH; Chen SU
J Formos Med Assoc; 2023 Jan; 122(1):29-35. PubMed ID: 36123235
[TBL] [Abstract][Full Text] [Related]
29. The Comparison of Fixed and Flexible Progestin Primed Ovarian Stimulation on Mature Oocyte Yield in Women at Risk of Premature Ovarian Insufficiency.
Kalafat E; Dizdar M; Turkgeldi E; Yildiz S; Keles I; Ata B
Front Endocrinol (Lausanne); 2021; 12():797227. PubMed ID: 35185784
[TBL] [Abstract][Full Text] [Related]
30. The comparison of two different protocols ultra-long versus medroxyprogesterone acetate in women with ovarian endometriosis: a prospective randomized controlled trial.
Guo H; Du T; Gao H; Xi Q; Wu L; Lyu Q; Zhu Q
Reprod Health; 2022 Oct; 19(1):198. PubMed ID: 36195878
[TBL] [Abstract][Full Text] [Related]
31. The effects of low-dose human chorionic gonadotropin combined with human menopausal gonadotropin protocol on women with hypogonadotropic hypogonadism undergoing ovarian stimulation for in vitro fertilization.
Jiang S; Kuang Y
Clin Endocrinol (Oxf); 2018 Jan; 88(1):77-87. PubMed ID: 28960429
[TBL] [Abstract][Full Text] [Related]
32. Different progestin-primed ovarian stimulation protocols in infertile women undergoing in vitro fertilization/intracytoplasmic sperm injection: an analysis of 1188 cycles.
Guo YC; Chen PY; Li TT; Jia L; Sun P; Zhu WS; Deng CC; Fang C; Liang XY
Arch Gynecol Obstet; 2019 Apr; 299(4):1201-1212. PubMed ID: 30852654
[TBL] [Abstract][Full Text] [Related]
33. Medroxyprogesterone acetate is a useful alternative to a gonadotropin-releasing hormone antagonist in oocyte donation: a randomized, controlled trial.
Giles J; Alama P; Gamiz P; Vidal C; Badia P; Pellicer A; Bosch E
Fertil Steril; 2021 Aug; 116(2):404-412. PubMed ID: 33814126
[TBL] [Abstract][Full Text] [Related]
34. Comparison Between PPOS and GnRHa-Long Protocol in Clinical Outcome with the First IVF/ICSI Cycle: A Randomized Clinical Trial.
Xi Q; Tao Y; Qiu M; Wang Y; Kuang Y
Clin Epidemiol; 2020; 12():261-272. PubMed ID: 32184672
[TBL] [Abstract][Full Text] [Related]
35. Progestin-primed ovarian stimulation protocol with or without clomiphene citrate for poor ovarian responders: a retrospective cohort study.
Liu A; Li J; Shen H; Zhang L; Li Q; Zhang X
BMC Womens Health; 2022 Dec; 22(1):527. PubMed ID: 36528555
[TBL] [Abstract][Full Text] [Related]
36. Non-inferiority of progestin-primed ovarian stimulation versus GnRH antagonist protocol: A propensity score-weighted analysis.
Duc Thang L; Bao Long H; Thi Thu Trang D; Ngoc Quy P; Thi Mai Phuong G; Thi Hanh B; Trong Thach T; Thi Lien Huong N; Hoang L; Hugues JN
J Formos Med Assoc; 2024 Apr; 123(4):523-529. PubMed ID: 38092654
[TBL] [Abstract][Full Text] [Related]
37. Progestin vs. Gonadotropin-Releasing Hormone Antagonist for the Prevention of Premature Luteinizing Hormone Surges in Poor Responders Undergoing
Chen Q; Chai W; Wang Y; Cai R; Zhang S; Lu X; Zeng X; Sun L; Kuang Y
Front Endocrinol (Lausanne); 2019; 10():796. PubMed ID: 31824419
[No Abstract] [Full Text] [Related]
38. Benefit from luteal phase progestin-primed ovarian stimulation with clomiphene citrate supplementation in young women with diminished ovarian reserve: a retrospective study.
Chen Q; Huang X; Yang H; Lin Y
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2024 May; ():1-9. PubMed ID: 38763766
[TBL] [Abstract][Full Text] [Related]
39. Comparison of a novel flexible progestin primed ovarian stimulation protocol and the flexible gonadotropin-releasing hormone antagonist protocol for assisted reproductive technology.
Yildiz S; Turkgeldi E; Angun B; Eraslan A; Urman B; Ata B
Fertil Steril; 2019 Oct; 112(4):677-683. PubMed ID: 31371053
[TBL] [Abstract][Full Text] [Related]
40. Gonadotropin versus Follicle-Stimulating Hormone for Ovarian Response in Patients Undergoing in vitro Fertilization: A Retrospective Cohort Comparison.
Ji Z; Quan X; Lan Y; Zhao M; Tian X; Yang X
Curr Ther Res Clin Exp; 2020; 92():100572. PubMed ID: 31908689
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
